Jay Saoud

1.7k total citations
24 papers, 626 citations indexed

About

Jay Saoud is a scholar working on Molecular Biology, Psychiatry and Mental health and Cognitive Neuroscience. According to data from OpenAlex, Jay Saoud has authored 24 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Psychiatry and Mental health and 8 papers in Cognitive Neuroscience. Recurrent topics in Jay Saoud's work include Schizophrenia research and treatment (8 papers), Sleep and Wakefulness Research (6 papers) and Sleep and related disorders (5 papers). Jay Saoud is often cited by papers focused on Schizophrenia research and treatment (8 papers), Sleep and Wakefulness Research (6 papers) and Sleep and related disorders (5 papers). Jay Saoud collaborates with scholars based in United States, Cyprus and France. Jay Saoud's co-authors include R. Luthringer, Michael Davidson, Corinne Staner, Sandra Werner, Gregory P. Strauss, Mark Weiser, B. Timothy Walsh, Philip D. Harvey, Jay S. Charleston and Peter Sazani and has published in prestigious journals such as New England Journal of Medicine, PLoS ONE and American Journal of Psychiatry.

In The Last Decade

Jay Saoud

22 papers receiving 603 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jay Saoud United States 13 228 160 120 111 91 24 626
Johannes Schröeder Germany 11 182 0.8× 60 0.4× 61 0.5× 53 0.5× 240 2.6× 21 715
P. Berner Austria 15 249 1.1× 113 0.7× 183 1.5× 48 0.4× 64 0.7× 60 739
Alexandre Méary France 13 611 2.7× 181 1.1× 59 0.5× 101 0.9× 217 2.4× 20 808
N. Zhao United States 11 101 0.4× 228 1.4× 30 0.3× 227 2.0× 87 1.0× 32 617
Valérie Jomphe Canada 12 273 1.2× 150 0.9× 100 0.8× 41 0.4× 103 1.1× 22 613
Leigh Townsend United Kingdom 7 142 0.6× 59 0.4× 36 0.3× 28 0.3× 62 0.7× 10 401
Michael Maier United Kingdom 14 296 1.3× 51 0.3× 76 0.6× 29 0.3× 342 3.8× 27 862
András Lászik Hungary 12 175 0.8× 159 1.0× 94 0.8× 65 0.6× 41 0.5× 28 508
Jean‐Romain Richard France 14 229 1.0× 97 0.6× 72 0.6× 47 0.4× 31 0.3× 27 599
Murielle Girard France 16 95 0.4× 43 0.3× 152 1.3× 30 0.3× 91 1.0× 48 672

Countries citing papers authored by Jay Saoud

Since Specialization
Citations

This map shows the geographic impact of Jay Saoud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jay Saoud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jay Saoud more than expected).

Fields of papers citing papers by Jay Saoud

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jay Saoud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jay Saoud. The network helps show where Jay Saoud may publish in the future.

Co-authorship network of co-authors of Jay Saoud

This figure shows the co-authorship network connecting the top 25 collaborators of Jay Saoud. A scholar is included among the top collaborators of Jay Saoud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jay Saoud. Jay Saoud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Krystal, Andrew D., Rama Melkote, Haiyan Xu, et al.. (2025). Efficacy and Safety of Seltorexant in Insomnia Disorder. JAMA Psychiatry. 82(10). 967–967.
2.
Ahmed, Anthony O., Philip D. Harvey, Jay Saoud, et al.. (2024). Network intervention analysis indicates that roluperidone achieves its effect on negative symptoms of schizophrenia by targeting avolition. European Neuropsychopharmacology. 87. 18–23. 5 indexed citations
3.
Rabinowitz, Jonathan, Corinne Staner, Jay Saoud, et al.. (2023). Long-term effects of Roluperidone on negative symptoms of schizophrenia. Schizophrenia Research. 255. 9–13. 12 indexed citations
4.
Thiesse, Laurie, Luc Staner, Patrice Bourgin, et al.. (2023). Somno-Art Software identifies pathology-induced changes in sleep parameters similarly to polysomnography. PLoS ONE. 18(10). e0291593–e0291593.
5.
Thiesse, Laurie, et al.. (2022). Performance of Somno-Art Software compared to polysomnography interscorer variability: A multi-center study. Sleep Medicine. 96. 14–19. 5 indexed citations
6.
Davidson, Michael, Jay Saoud, Corinne Staner, et al.. (2022). Efficacy and Safety of Roluperidone for the Treatment of Negative Symptoms of Schizophrenia. Schizophrenia Bulletin. 48(3). 609–619. 45 indexed citations
7.
Thiesse, Laurie, Luc Staner, Patrice Bourgin, et al.. (2021). Validation of Somno-Art Software, a novel approach of sleep staging, compared with polysomnography in disturbed sleep profiles. SLEEP Advances. 3(1). zpab019–zpab019. 6 indexed citations
8.
Strauss, Gregory P., Farnaz Zamani Esfahlani, Hiroki Sayama, et al.. (2019). Network Analysis Indicates That Avolition Is the Most Central Domain for the Successful Treatment of Negative Symptoms: Evidence From the Roluperidone Randomized Clinical Trial. Schizophrenia Bulletin. 46(4). 964–970. 51 indexed citations
9.
10.
Keefe, Richard S.E., Philip D. Harvey, Anzalee Khan, et al.. (2018). Cognitive Effects of MIN-101 in Patients With Schizophrenia and Negative Symptoms. The Journal of Clinical Psychiatry. 79(3). 25 indexed citations
11.
Kirkpatrick, Brian, Jay Saoud, Gregory P. Strauss, et al.. (2017). The brief negative symptom scale (BNSS): Sensitivity to treatment effects. Schizophrenia Research. 197. 269–273. 20 indexed citations
12.
Davidson, Michael, Jay Saoud, Corinne Staner, et al.. (2017). Efficacy and Safety of MIN-101: A 12-Week Randomized, Double-Blind, Placebo-Controlled Trial of a New Drug in Development for the Treatment of Negative Symptoms in Schizophrenia. American Journal of Psychiatry. 174(12). 1195–1202. 74 indexed citations
13.
14.
Heald, Alison E., Jay S. Charleston, Patrick L. Iversen, et al.. (2015). AVI-7288 for Marburg Virus in Nonhuman Primates and Humans. New England Journal of Medicine. 373(4). 339–348. 40 indexed citations
15.
16.
17.
18.
Rusnak, James M., Stephen L. Kopecky, Ian P. Clements, et al.. (2001). An anti-CD11/CD18 monoclonal antibody in patients with acute myocardial infarction having percutaneous transluminal coronary angioplasty (the FESTIVAL study). The American Journal of Cardiology. 88(5). 482–487. 56 indexed citations
19.
Hollander, Eric, Dan J. Stein, Concetta DeCaria, et al.. (1994). Serotonergic sensitivity in borderline personality disorder: preliminary findings. American Journal of Psychiatry. 151(2). 277–280. 72 indexed citations
20.
Saoud, Jay, et al.. (1994). Childhood abuse, family environment, and outcome in bulimia nervosa.. PubMed. 55(10). 424–8. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johannes Schröeder Breakdown of academic impact, for papers by P. Berner Breakdown of academic impact, for papers by Alexandre Méary Breakdown of academic impact, for papers by N. Zhao Breakdown of academic impact, for papers by Valérie Jomphe Breakdown of academic impact, for papers by Leigh Townsend Breakdown of academic impact, for papers by Michael Maier Breakdown of academic impact, for papers by András Lászik Breakdown of academic impact, for papers by Jean‐Romain Richard Breakdown of academic impact, for papers by Murielle Girard
Rankless by CCL
2026